Generic Oncology Drugs Market Surpasses US$24.4 billion in 2022, Set to Grow at CAGR 6.5% through 2033 | Persistence Market Research New York, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The global market for generic oncology drugs is estimated to be worth US$24.4 billion in 2022, with a 6.5% CAGR to reach US$49.9 billion by the end of...

Two-Thirds of Biopharma Sponsors Surveyed Currently Sell or Plan to Sell Biosimilar Products CARY, NC--(Marketwired - May 17, 2016) - A new report titled Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (3rd edition) from Industry Standard Research (ISR),...

Sponsors Anticipate Considerable Growth in Outsourced Bioprocessing Over the Next Five Years CARY, NC--(Marketwired - April 26, 2016) - A new report titled Bioprocessing Market Trends and Outsourcing Dynamics: 2016-2021, from Industry Standard Research (ISR), indicates considerable...